Bhawna Chandravanshi

发表

Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function

M. K. Verma, M. Sadasivuni, A. N. Yateesh, 2014, BMC Cell Biology.

Response of Chick B Islets to Insulin Secretagogues is Comparable to those of Human Islet Equivalents

Bhawna Chandravanshi, R. Bhonde, S. Datar, 2015 .

Small molecules exert anti-apoptotic effect and reduce oxidative stress augmenting insulin secretion in stem cells engineered islets against hypoxia.

Bhawna Chandravanshi, R. Bhonde, 2016, European journal of pharmacology.

Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis

D. Meyerholz, Bhawna Chandravanshi, S. Summers, 2022, Scientific Reports.

A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro

M. K. Verma, K. Neelima, S. Biswas, 2014, BMC Research Notes.

Pancreatic Progenitors as Target for Islet Neogenesis to Manage Diabetes

Bhawna Chandravanshi, R. Bhonde, 2017 .

Hypoxia primed placental mesenchymal stem cells for wound healing

Bhawna Chandravanshi, R. Bhonde, S. Mathew, 2017, Life sciences.

IGF‐1 and somatocrinin trigger islet differentiation in human amniotic membrane derived mesenchymal stem cells

Bhawna Chandravanshi, Aparna V. Dubhashi, R. Bhonde, 2019, Life sciences.

Shielding Engineered Islets With Mesenchymal Stem Cells Enhance Survival Under Hypoxia

Bhawna Chandravanshi, R. Bhonde, 2017, Journal of cellular biochemistry.

Herbal pre-conditioning induces proliferation and delays senescence in Wharton's Jelly Mesenchymal Stem Cells.

Bhawna Chandravanshi, K. Joshi, G. Tillu, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

High Recovery of Functional Islets Stored at Low and Ultralow Temperatures.

Bhawna Chandravanshi, R. Bhonde, A. Dhanushkodi, 2014, The review of diabetic studies : RDS.

Reprogramming mouse embryo fibroblasts to functional islets without genetic manipulation

Bhawna Chandravanshi, R. Bhonde, 2018, Journal of cellular physiology.

CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients

M. K. Verma, M. Sadasivuni, Bhawna Chandravanshi, 2014, BMC Pharmacology and Toxicology.

A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro

M. K. Verma, Bhawna Chandravanshi, Anup M Oommen, 2014, BMC Research Notes.